0001562180-23-001539.txt : 20230217
0001562180-23-001539.hdr.sgml : 20230217
20230217204608
ACCESSION NUMBER: 0001562180-23-001539
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mango Lisa A
CENTRAL INDEX KEY: 0001800511
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39203
FILM NUMBER: 23644972
MAIL ADDRESS:
STREET 1: C/O 1LIFE HEALTHCARE, INC.
STREET 2: ONE EMBARCADERO CENTER, SUITE 1900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 1Life Healthcare Inc
CENTRAL INDEX KEY: 0001404123
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 760707204
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 1900
CITY: San Francisco
STATE: CA
ZIP: 94111
BUSINESS PHONE: (415) 814-0927
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 1900
CITY: San Francisco
STATE: CA
ZIP: 94111
FORMER COMPANY:
FORMER CONFORMED NAME: 1life Healthcare Inc
DATE OF NAME CHANGE: 20070621
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2023-02-15
false
0001404123
1Life Healthcare Inc
ONEM
0001800511
Mango Lisa A
C/O 1LIFE HEALTHCARE, INC.
ONE EMBARCADERO CENTER, SUITE 1900
SAN FRANCISCO
CA
94111
false
true
false
false
General Counsel and Secretary
Common Stock
2023-02-15
4
M
false
11525.00
A
99910.00
D
Common Stock
2023-02-15
4
M
false
2221.00
A
102131.00
D
Common Stock
2023-02-16
4
S
false
7596.00
15.356
D
94535.00
D
Common Stock
2023-02-17
4
S
false
6150.00
15.3197
D
88385.00
D
Restricted Stock Units
2023-02-15
4
M
false
11525.00
0.00
D
Common Stock
11525.00
34573.00
D
Restricted Stock Units
2023-02-15
4
M
false
2221.00
0.00
D
Common Stock
2221.00
4441.00
D
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units ("RSUs") convert into the issuer's common stock on a one-for-one basis.
Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the reporting person.
This transaction was executed in multiple trades at prices ranging from $15.31 to $15.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
This transaction was executed in multiple trades at prices ranging from $15.30 to $15.355. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The RSUs vest in equal annual installments over four years on the anniversary of the vesting commencement date, subject to the reporting person's continuous service as of each such date.
/s/ Ivy Tseng, Attorney-in-Fact for Lisa A Mango
2023-02-17
EX-24
2
lmangopoa.txt
POA
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby
constitutes and appoints each of BJORN B. THALER, MATTHEW B. HEMINGTON and
IVY TSENG, signing individually, the undersigned's true and lawful
attorneys-in fact and agents to:
(1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer, director or beneficial
owner of more than 10% of a registered class of securities of
1Life Healthcare, Inc. (the "Company"), Forms 3, 4 and 5
(including any amendments thereto) in accordance with Section
16(a) of the Securities Exchange Act of 1934, as amended (the
"Exchange Act") and the rules thereunder and a Form ID, Uniform
Application for Access Codes to File on EDGAR;
(2) do and perform any and all acts for and on behalf of the
undersigned that may be necessary or desirable to execute such
Forms 3, 4 or 5 or Form ID (including any amendments thereto)
and timely file such forms with the United States Securities and
Exchange Commission and any stock exchange or similar authority;
and
(3) take any other action of any nature whatsoever in
connection with the foregoing which, in the opinion of such
attorney-in-fact, may be of benefit, in the best interest of, or
legally required by, the undersigned, it being understood that
the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such
form and shall contain such terms and conditions as such
attorney-in-fact may approve in such attorney-in-fact's
discretion.
The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing
whatsoever requisite, necessary or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all
intents and purposes as the undersigned might or could do if
personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do
or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that
the foregoing attorneys-in-fact, in serving in such capacity at the
request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect
until the earliest to occur of (a) the undersigned is no longer
required to file Forms 3, 4 and 5 with respect to the undersigned's
holdings of and transactions in securities issued by the Company, (b)
revocation by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact or (c) as to any attorney-in-fact
individually, until such attorney-in-fact is no longer employed by
the Company or Cooley LLP. The undersigned hereby acknowledges that
this Power of Attorney supersedes, revokes and terminates any power
of attorney executed by the undersigned prior to the date hereof for
the purposes listed above.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of Date: May 7, 2021.
/s/ Lisa Mango
Lisa Mango